-+ 0.00%
-+ 0.00%
-+ 0.00%

60 DEGREES PHARMACEUTICALS ANNOUNCES POSITIVE RECOMMENDATION FROM DATA SAFETY MONITORING BOARD FOR B-FREE PHASE 2 STUDY OF TAFENOQUINE FOR TREATMENT OF CHRONIC BABESIOSIS PATIENTS WITH SEVERE FATIGUE

Reuters·07/01/2026 12:02:00

Please log in to view news